Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of intravitreal bevacizumab
injection (IVBI) with respect to simple observation in patients with subfoveal choroidal
neovascularisation (CNV) secondary to age-related macular degeneration (AMD) presenting at
baseline with best corrected visual acuity (BCVA) less than 20/200.